Skip to content

APOTEEK MOMMAERT: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTEEK MOMMAERT

BE 0414.393.205
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€40,905
2024 · €56,285-€15,380
Equity
€871,016
2024 · €830,110+€40,905
Cash
€181,497
2024 · €212,374-€30,877
Balance sheet total
€1.1m
2024 · €1.0m+€89,193

Largest movements

2024 to 2025
Assets
  • Current investments +€85,907

    up €85,907 (+20.2%), from €425,010 to €510,917

  • Receivables within one year +€33,849

    up €33,849 (+16.2%), from €209,562 to €243,411

    of which Other amounts receivable: +€37,032

  • Cash -€30,877

    down €30,877 (-14.5%), from €212,374 to €181,497

    mainly Current investments (-€85,907) and Receivables within one year (-€33,849)

  • Tangible fixed assets -€16,273

    down €16,273 (-42.2%), from €38,582 to €22,309

    of which Land and buildings: -€14,654

  • Stocks and contracts +€14,629

    up €14,629 (+13.4%), from €109,186 to €123,816

Equity and liabilities
  • Trade debts +€51,977

    up €51,977 (+69.1%), from €75,234 to €127,211

  • Reserves +€40,905

    up €40,905 (+20.3%), from €201,604 to €242,509

    of which Distributable reserves: +€40,905

Income statement
  • Gross operating margin -€45,857

    down €45,857 (-26.1%), from €175,991 to €130,134

  • Financial income +€18,679

    up €18,679 (+248%), from €7,529 to €26,208

  • Taxes -€12,510

    down €12,510 (-39.8%), from €31,404 to €18,894

  • Staff costs +€6,887

    up €6,887 (+10.2%), from €67,678 to €74,565

  • Financial charges -€5,942

    down €5,942 (-65.4%), from €9,092 to €3,149

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €56,285
Gross operating margin -€45,857
Staff costs -€6,887
Depreciation +€733
Other operating charges -€501
Financial income +€18,679
Financial charges +€5,942
Taxes +€12,510
Result 2025 €40,905
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€55,029
Investment -€85,907
Financing €0
Cash 2024 €212,374
Net result for the year +€40,905
Depreciation +€16,273
Stocks and contracts -€14,629
Receivables within one year -€33,849
Deferred charges and accrued income -€1,958
Trade debts +€51,977
Tax, wage and social debts -€3,689
Current investments -€85,907
Cash 2025 €181,497
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,000,931 €1,090,124 +€89,193 +8.9%
Fixed assets 21/28 €38,582 €22,309 -€16,273 -42.2%
Tangible fixed assets 22/27 €38,582 €22,309 -€16,273 -42.2%
Land and buildings 22 €34,659 €20,005 -€14,654 -42.3%
Plant, machinery and equipment 23 €3,339 €2,304 -€1,035 -31.0%
Furniture and vehicles 24 €584 - -€584
Current assets 29/58 €962,349 €1,067,815 +€105,466 +11.0%
Stocks and contracts in progress 3 €109,186 €123,816 +€14,629 +13.4%
Stocks 30/36 €109,186 €123,816 +€14,629 +13.4%
Amounts receivable within one year 40/41 €209,562 €243,411 +€33,849 +16.2%
Trade receivables 40 €80,811 €77,628 -€3,183 -3.9%
Other amounts receivable 41 €128,751 €165,783 +€37,032 +28.8%
Current investments 50/53 €425,010 €510,917 +€85,907 +20.2%
Cash at bank and in hand 54/58 €212,374 €181,497 -€30,877 -14.5%
Deferred charges and accrued income 490/1 €6,217 €8,175 +€1,958 +31.5%
Total equity and liabilities 10/49 €1,000,931 €1,090,124 +€89,193 +8.9%
Equity 10/15 €830,110 €871,016 +€40,905 +4.9%
Contributions 10/11 €61,973 €61,973 = 0.0%
Capital 10 €61,973 €61,973 = 0.0%
Issued capital 100 €61,973 €61,973 = 0.0%
Reserves 13 €201,604 €242,509 +€40,905 +20.3%
Non-distributable reserves 130/1 €6,197 €6,197 = 0.0%
Legal reserve 130 €6,197 €6,197 = 0.0%
Distributable reserves 133 €195,407 €236,312 +€40,905 +20.9%
Profit (loss) carried forward 14 €566,533 €566,533 = 0.0%
Provisions and deferred taxes 16 €79,326 €79,326 = 0.0%
Provisions for liabilities and charges 160/5 €79,326 €79,326 = 0.0%
Pensions and similar obligations 160 €79,326 €79,326 = 0.0%
Amounts payable 17/49 €91,495 €139,783 +€48,288 +52.8%
Amounts payable within one year 42/48 €91,495 €139,783 +€48,288 +52.8%
Trade debts 44 €75,234 €127,211 +€51,977 +69.1%
Suppliers 440/4 €75,234 €127,211 +€51,977 +69.1%
Taxes, remuneration and social security 45 €16,261 €12,572 -€3,689 -22.7%
Taxes 450/3 €4,648 €9 -€4,639 -99.8%
Remuneration and social security 454/9 €11,613 €12,563 +€950 +8.2%
Remuneration, social security and pensions 62 €67,678 €74,565 +€6,887 +10.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €17,006 €16,273 -€733 -4.3%
Other operating charges 640/8 €2,055 €2,556 +€501 +24.4%
Gross operating margin 9900 €175,991 €130,134 -€45,857 -26.1%
Operating profit (loss) 9901 €89,252 €36,741 -€52,511 -58.8%
Financial income 75/76B €7,529 €26,208 +€18,679 +248%
Recurring financial income 75 €7,529 €26,208 +€18,679 +248%
Financial charges 65/66B €9,092 €3,149 -€5,942 -65.4%
Recurring financial charges 65 €9,092 €3,149 -€5,942 -65.4%
Profit (loss) for the period before taxes 9903 €87,689 €59,799 -€27,890 -31.8%
Income taxes 67/77 €31,404 €18,894 -€12,510 -39.8%
Profit (loss) for the period 9904 €56,285 €40,905 -€15,380 -27.3%
Profit (loss) for the period to be appropriated 9905 €56,285 €40,905 -€15,380 -27.3%

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.